Oscar Health Inc (NYSE:OSCR) price on Tuesday, December 24, fall -1.47% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $13.40.
A look at the stock’s price movement, the close in the last trading session was $13.60, moving within a range at $13.06 and $13.655. The beta value (5-Year monthly) was 1.664. Turning to its 52-week performance, $23.79 and $8.44 were the 52-week high and 52-week low respectively. Overall, OSCR moved -16.15% over the past month.
Oscar Health Inc’s market cap currently stands at around $3.26 billion, with investors looking forward to this quarter’s earnings report slated for in January.
Analysts have a consensus estimate of 2.47B for the company’s revenue for the quarter, with a low and high estimate of 2.45B and 2.5B respectively. The average forecast suggests up to a 72.68% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 9.26B, representing a 57.84% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that OSCR is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 2 analyst(s) rate the stock as a Hold, 3 recommend OSCR as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
OSCR’s current price about -11.97% and -14.90% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 39.27, while 7-day volatility ratio is 7.34% and 7.36% in the 30-day chart. Further, Oscar Health Inc (OSCR) has a beta value of 1.67, and an average true range (ATR) of 1.15. Analysts have given the company’s stock an average 52-week price target of $28, forecast between a low of $28 and high of $28. Looking at the price targets, the low is -108.96% off current price level while to achieve the yearly target high, price needs to move -108.96%. Nonetheless, investors will most likely welcome a -108.96% jump to $28 which is the analysts’ median price.
If we refocus on Oscar Health Inc (NYSE:OSCR), historical trading data shows that trading volumes averaged 4.26 over the past 10 days and 4.15 million over the past 3 months. The company’s latest data on shares outstanding shows there are 211.70 million shares.
The 29.51% of Oscar Health Inc’s shares are in the hands of company insiders while institutional holders own 61.52% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 16.93 million on 2024-11-29, giving us a short ratio of 3.24. The data shows that as of 2024-11-29 short interest in Oscar Health Inc (OSCR) stood at 835.00005 of shares outstanding, with shares short rising to 12.41 million registered in 2024-10-31. Current price change has pushed the stock 46.45% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the OSCR stock continues to rise going into the next quarter.
